Understand the key trends shaping demand and future opportunities...
Understand the key trends shaping demand and future opportunities across industries in Eastern Europe, with the latest regional and country-level analysis and market statistics.
Dermatologicals is projected to continue to post strong retail current value growth in 2023. Increasing retail value sales have, on the one hand, been influenced by rising unit prices, amid a highly inflationary climate. In addition, hair loss…
International players with broad portfolios continue to lead the way in dermatologicals, with Bayer Romania the top-ranked company. Bayer Romania’s Canesten, the best-selling product in both topical and vaginal antifungals, is expected to maintain…
Most types of dermatologicals saw an upward sales trend in retail volume terms in 2023, although the rate of expansion was lower than that seen in many other consumer health categories. Despite the increasing incidence of diagnosed skin diseases…
Sales of dermatologicals have benefited from the return to normal activities following the lifting of pandemic-related restrictions. Consumers are out in public again and socialising and are consequently looking to treat any conditions to ensure thy…
In 2022, cough, cold and allergy (hay fever) remedies was marked by increases in demand for products to soothe sore throat and cough complaints. This development was a result of extremely high morbidity throughout the year. In the first half of 2022,…
Following the return to normality in the wake of the COVID-19 crisis, with no more lockdowns or movement restrictions, there has been an increase in the spread of cold and flu viruses, as well as a widespread rise in issues caused by hay fever and…
The majority of subcategories within cough, cold and allergy remedies recorded positive growth in retail volume terms in 2023. This was due, in a large part, to a return pre-pandemic lifestyles, which facilitated the spread of the influenza virus and…
Whilst the category continues to record growth in 2023, the particularly high growth level seen in the previous year could not be maintained. 2022 was a strong year for the category as consumers returned to their pre-pandemic lifestyles following the…
In 2022, consumer health in the Czech Republic was challenged by medicine shortages, which, to some degree, continued in Q1 2023. The lack of some medicines in the Czech Republic and throughout Europe was caused by the disruption of global supply…
Despite ongoing economic instability and the high rate of inflation, the consumer health market in Romania is witnessing steady growth in 2023. Notably, it is the categories of vitamin and dietary supplements, cough, cold and allergy (hay fever)…